T-ALL research hub

Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cell Acute Lymphoblastic Leukemia

This study is testing a new drug, Isatuximab, for adults with a type of blood cancer called T-cell Acute Lymphoblastic Leukemia (T-ALL) that has come back or isn't responding to treatment. It looks at two groups of patients to see if the drug can help.